Cigna Corporation (CI) vs Regeneron Pharmaceuticals, Inc. (REGN)
CI leads on 11 of 17 compared metrics.
A side-by-side comparison of Cigna Corporation and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CI
Cigna Corporation
$298.00Healthcare
REGN
Regeneron Pharmaceuticals, Inc.
$612.14Healthcare
Total return — CI vs REGN
growth of $100 · last 30yCI +2330.7%REGN +3436.3%REGN compounded faster
CI REGN
CI vs REGN: by the numbers
- •CI is the larger company ($78.83B vs $63.06B market cap).
- •CI trades at the lower earnings multiple (12.64 vs 14.92 P/E).
- •REGN converts more revenue to profit (29.65% vs 2.26% net margin).
- •CI grew revenue faster over the past five years (11.28% vs 10.16% CAGR).
- •CI pays the higher dividend yield (2.06% vs 0.59%).
Which is better, CI or REGN?
Metric tally: CI 11 · REGN 6It depends on what you're optimizing for:
ValueCI(lower P/E)
GrowthCI(faster 5Y revenue CAGR)
IncomeCI(higher dividend yield)
QualityREGN(higher ROIC)
Valuation
| Metric | CI | REGN |
|---|---|---|
| P/E ratio | 12.64● | 14.92 |
| Forward P/E | 8.91● | 11.30 |
| P/S ratio | 0.28● | 4.42 |
| P/B ratio | 1.87● | 2.10 |
| PEG ratio | 0.15● | 3.38 |
| EV / EBITDA | 8.41● | 11.43 |
| FCF yield | 9.73%● | 6.30% |
Profitability
| Metric | CI | REGN |
|---|---|---|
| Gross margin | 9.30% | 84.55%● |
| Operating margin | 3.42% | 24.32%● |
| Net margin | 2.26% | 29.65%● |
| ROE | 14.90%● | 14.08% |
| ROIC | 7.35% | 8.51%● |
Dividends
| Metric | CI | REGN |
|---|---|---|
| Dividend yield | 2.06%● | 0.59% |
| Payout ratio | 27.53% | 8.45% |
Growth (annualized)
| Metric | CI | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 11.28%● | 10.16% |
| EPS CAGR (5Y) | -0.76% | 5.70%● |
| FCF CAGR (5Y) | -2.03% | 15.42%● |
| Total return CAGR (5Y) | 6.19%● | 3.26% |
Frequently asked
- Which is better, CI or REGN?
- It depends on your goal. value: CI (lower P/E); growth: CI (faster 5Y revenue CAGR); income: CI (higher dividend yield); quality: REGN (higher ROIC). Across all compared metrics, CI leads 11 to 6.
- Is CI or REGN cheaper?
- On trailing earnings, CI is cheaper: CI trades at a 12.64 P/E and REGN at 14.92.
- Which has grown faster, CI or REGN?
- Over the past five years, CI grew revenue faster — CI at a 11.28% CAGR versus REGN at 10.16%.
- Does CI or REGN pay a bigger dividend?
- CI yields 2.06% and REGN yields 0.59% based on trailing dividends and the latest price.
- Is CI or REGN more profitable?
- REGN runs the higher net margin — CI at 2.26% versus REGN at 29.65%.
- Which has been the better investment, CI or REGN?
- Over the past 10-year, CI delivered the higher annualized total return — CI at 9.91% versus REGN at 5.19%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cigna P/E ratioRegeneron Pharmaceuticals P/E ratioCigna dividend yieldRegeneron Pharmaceuticals dividend yieldCigna ROERegeneron Pharmaceuticals ROECigna operating marginRegeneron Pharmaceuticals operating marginCigna revenue growthRegeneron Pharmaceuticals revenue growthCigna free cash flowRegeneron Pharmaceuticals free cash flow
Cigna & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.